Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Vaccinia Virus B18R (VACV B18R) (AA 20-351) (Active) protein (His tag)

VACV B18R Origin: Vaccinia Virus (VACV) Host: HEK-293 Cells Recombinant >95 % as determined by SDS-PAGE. Active
Catalog No. ABIN2870854
  • Target
    Vaccinia Virus B18R (VACV B18R)
    Protein Type
    Recombinant
    Biological Activity
    Active
    Protein Characteristics
    AA 20-351
    Origin
    Vaccinia Virus (VACV)
    Source
    • 1
    • 1
    HEK-293 Cells
    Purification tag / Conjugate
    His tag
    Sequence
    AA 20-351
    Characteristics
    This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 40.3 kDa. The protein migrates as 50-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
    Purity
    >95 % as determined by SDS-PAGE.
    Endotoxin Level
    Less than 1.0 EU per μg by the LAL method.
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Handling Advice
    Please avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
  • Target
    Vaccinia Virus B18R (VACV B18R)
    Alternative Name
    B18R
    Target Type
    Viral Protein
    Background
    B18R is a type I interferon (IFN)-binding protein and it is encoded by the B18R open reading frame in the WR (Western Reserve) strain of vaccinia virus, which contains two Ig-like C2-type domains and one Ig-like V-type domain. B18R exists in a soluble and a membrane-bound form. As a type I IFN receptor, B18R counteracts the antiviral effects of host IFN-alpha/beta. Also, B18R acts as a soluble IFN-alpha receptor and thus inhibits the interaction between host IFN-alpha and its receptor.
    Molecular Weight
    40.3 kDa
    UniProt
    P25213
You are here:
Support